{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:47:36Z","timestamp":1793746056578,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejso.2022.05.010","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T17:59:43Z","timestamp":1652723983000},"page":"1061-1067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9726-9732","authenticated-orcid":false,"given":"S.","family":"Bonvalot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-0087","authenticated-orcid":false,"given":"C.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-3221","authenticated-orcid":false,"given":"C.","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Le P\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tzanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4703-3534","authenticated-orcid":false,"given":"A.","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejso.2022.05.010_bib1","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1002\/cncr.27555","article-title":"Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions","volume":"118","author":"Mastrangelo","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.05.010_bib2","unstructured":"WHO classification of tumours, fifth ed., volume vol. 3: Soft tissue and bone tumours. (2020). Accessed : August 24, 2021: https:\/\/www.iarc.who.int\/news-events\/publication-of-the-who-classification-of-tumours-5th-edition-volume-3-soft-tissue-and-bone-tumours\/."},{"issue":"11","key":"10.1016\/j.ejso.2022.05.010_bib3","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.05.010_bib4","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.6004\/jnccn.2020.0058","article-title":"NCCN guidelines insights: soft tissue sarcoma, version 1.2021","volume":"18","author":"von Mehren","year":"2020","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"key":"10.1016\/j.ejso.2022.05.010_bib5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S1470-2045(20)30446-0","article-title":"Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial","volume":"21","author":"Bonvalot","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.05.010_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158406","article-title":"Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort)","volume":"12","author":"Derbel","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1245\/s10434-014-3965-2","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group","volume":"22","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2022.05.010_bib8","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1245\/s10434-021-09654-z","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic Australasian RPS working group","volume":"28","author":"Swallow","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.05.010_bib9","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.ejso.2020.04.054","article-title":"Overview of primary adult retroperitoneal tumours","volume":"46","author":"Improta","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2022.05.010_bib10","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ejso.2017.06.009","article-title":"Needle tract seeding following core biopsies in retroperitoneal sarcoma","volume":"43","author":"Van Houdt","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.05.010_bib11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1245\/s10434-014-4059-x","article-title":"Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival","volume":"22","author":"Wilkinson","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2022.05.010_bib12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ejso.2016.10.032","article-title":"Primary retroperitoneal soft tissue sarcoma: imaging appearances, pitfalls and diagnostic algorithm","volume":"43","author":"Messiou","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2022.05.010_bib13","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1093\/annonc\/mdx484","article-title":"Improved survival using specialized multidisciplinary board in sarcoma patients","volume":"28","author":"Blay","year":"2017","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.05.010_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejso.2018.07.001","article-title":"Role of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience","volume":"45","author":"Kirov","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jamcollsurg.2019.09.013","article-title":"Identifying the minimum volume threshold for retroperitoneal soft tissue sarcoma resection: merging national data with consensus expert opinion","volume":"230","author":"Villano","year":"2020","journal-title":"J\u00a0Am Coll Surg"},{"issue":"23","key":"10.1016\/j.ejso.2022.05.010_bib16","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1002\/cncr.31699","article-title":"Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma","volume":"124","author":"Keung","year":"2018","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2022.05.010_bib17","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1245\/s10434-019-07421-9","article-title":"Survival benefit of the surgical management of retroperitoneal sarcoma in a reference center: a nationwide study of the French sarcoma group from the NetSarc database","volume":"26","author":"Bonvalot","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2022.05.010_bib18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-199809000-00008","article-title":"Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution","volume":"228","author":"Lewis","year":"1998","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1200\/JCO.2008.18.0802","article-title":"Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control","volume":"27","author":"Bonvalot","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1200\/JCO.2008.17.8871","article-title":"Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients","volume":"27","author":"Gronchi","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.05.010_bib21","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1245\/s10434-012-2342-2","article-title":"Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG","volume":"19","author":"Bonvalot","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1200\/JCO.2008.18.7138","article-title":"Resection of some - but not all - clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas","volume":"27","author":"Pisters","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.05.010_bib23","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1245\/s10434-014-4135-2","article-title":"Extended surgical resection and histology in retroperitoneal sarcoma","volume":"22","author":"Crago","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2022.05.010_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/annonc\/mdr323","article-title":"Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas","volume":"23","author":"Gronchi","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.05.010_bib25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1245\/s10434-014-4130-7","article-title":"Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection","volume":"22","author":"Gronchi","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.05.010_bib26","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","article-title":"Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-institutional Collaborative RPS Working Group","volume":"263","author":"Gronchi","year":"2016","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2022.05.010_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/SLA.0000000000002250","article-title":"Postoperative morbidity after radical resection of primary retroperitoneal sarcoma: a report from the transatlantic RPS working group","volume":"267","author":"Mac Neill","year":"2018","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.ejso.2022.05.010_bib28","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1245\/s10434-011-1742-z","article-title":"Retroperitoneal sarcoma: is it time to change the surgical policy?","volume":"18","author":"Mussi","year":"2011","journal-title":"Ann Surg Oncol Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jso.24919","article-title":"Current principles of surgery for retroperitoneal sarcomas","volume":"117","author":"Fairweather","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib30","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1245\/s10434-017-6136-4","article-title":"Surgical management of primary retroperitoneal sarcomas: rationale for selective organ resection","volume":"25","author":"Fairweather","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.05.010_bib31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jamcollsurg.2017.01.044","article-title":"Incidence and adverse prognostic implications of histopathologic organ invasion in primary retroperitoneal sarcoma","volume":"224","author":"Fairweather","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ejso.2022.05.010_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jso.24920","article-title":"Major vascular resections in retroperitoneal sarcoma","volume":"117","author":"Tzanis","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.05.010_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1245\/s10434-011-1954-2","article-title":"Surgical technique, morbidity, and outcome of primary retroperitoneal sarcoma involving inferior vena cava","volume":"19","author":"Fiore","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2022.05.010_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.05.010_bib35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","article-title":"Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma","volume":"14","author":"Pisters","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2022.05.010_bib36","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(16)30050-X","article-title":"Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database","volume":"17","author":"Nussbaum","year":"2016","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2022.05.010_bib37","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.31927","article-title":"Radiotherapy for retroperitoneal liposarcoma: a report from the transatlantic retroperitoneal sarcoma working group","volume":"125","author":"Haas","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2022.05.010_bib38","article-title":"Preoperative Radiotherapy in patients with primary retroperitoneal sarcoma (RPS): trial (STRASS) vs off-trial (STREXIT) results","author":"Callegaro","year":"2020","journal-title":"Connective Tissue Oncol Soc Meet Final Prog"},{"key":"10.1016\/j.ejso.2022.05.010_bib39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2019.11.011","article-title":"Radiotherapy in the treatment of extracranial hemangiopericytoma\/solitary fibrous tumor: study from the Rare Cancer Network","volume":"144","author":"Krengli","year":"2020","journal-title":"Radiother Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2022.05.010_bib40","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1002\/cncr.32911","article-title":"Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: a retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet","volume":"126","author":"Haas","year":"2020","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.ejso.2022.05.010_bib41","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.19.03289","article-title":"Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and polish (PSG) sarcoma groups","volume":"38","author":"Gronchi","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2022.05.010_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.suronc.2017.01.008","article-title":"Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: evidence from a nationwide clinical oncology database and review of the literature","volume":"26","author":"Datta","year":"2017","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2022.05.010_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/cncr.33323","article-title":"Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: a multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group","volume":"127","author":"Tseng","year":"2021","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2022.05.010_bib44","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/cancers14041064","article-title":"Novel therapeutic options for solitary fibrous tumor: antiangiogenic therapy and beyond","volume":"14","author":"de Bernardi","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejso.2022.05.010_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S1470-2045(19)30826-5","article-title":"Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial","volume":"21","author":"Martin-Broto","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2022.05.010_bib46","first-page":"1","article-title":"Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor","author":"Baldi","year":"2022","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322004358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798322004358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:46:19Z","timestamp":1760060779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798322004358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0748798322004358"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2022.05.010","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histology-tailored multidisciplinary management of primary retroperitoneal sarcomas","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2022.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}